Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology / Q000601:surgery; D002272:Carcinoembryonic Antigen / Q000097:blood*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008408:Mastectomy / Q000379:methods; D018396:Mucin-1 / Q000097:blood*; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging / Q000379:methods; D012680:Sensitivity and Specificity; D019396:Tissue Polypeptide Antigen / Q000097:blood*
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D018396:Mucin-1; D019396:Tissue Polypeptide Antigen